Diagnostic method for alzheimer's disease based on holo-transcobalamin II
US7294514B2 · kind B2 · utility
0Cited by
3References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 22, 2001 |
| Grant date | Nov 13, 2007 |
| Priority date | — |
| Expiry date | May 22, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides a diagnostic or prognostic assay method for Alzheimer's Disease by assaying a body fluid sample or a test sample derived therefrom for holo-trancobalamin II.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.